Neurobehavioral Differences in Superselective Wada Testing with Amobarbital Versus Lidocaine
Overview
Affiliations
Four patients with cerebral arteriovenous malformations (AVMs) underwent superselective Wada testing with intraarterial amobarbital and lidocaine before embolization. In all four patients, the use of lidocaine detected clinically significant neurologic deficits that amobarbital alone did not, likely because of the pharmacodynamic differences of the two agents. The use of lidocaine with amobarbital for superselective Wada testing in patients with cerebral AVMs may improve the sensitivity and predictive value of this test in the future.
Provocative Testing Prior to Anterior Cerebral Artery Fusiform Aneurysm Embolization.
Moshayedi P, Giurgiutiu D, Ducruet A, Jankowitz B, Jadhav A Interv Neurol. 2018; 7(1-2):36-41.
PMID: 29628943 PMC: 5881155. DOI: 10.1159/000482012.
Embolization of Sacral Dural Arteriovenous Fistulas: A Case Series and Literature Review.
Alvarado A, Haussen D, Ebersole K, Nogueira R, Abraham M Interv Neurol. 2017; 6(1-2):73-81.
PMID: 28611837 PMC: 5465750. DOI: 10.1159/000454929.
Fusco M, Stapleton C, Griessenauer C, Thomas A, Ogilvy C Interv Neuroradiol. 2015; 22(2):148-52.
PMID: 26672110 PMC: 4984342. DOI: 10.1177/1591019915617326.
Gonzalez J, Llibre Guerra J, Prince Lopez J, Vazquez Luna F, Rodriguez Ramos R, Ugarte Suarez J Interv Neuroradiol. 2013; 19(3):320-8.
PMID: 24070081 PMC: 3806007. DOI: 10.1177/159101991301900309.
Feliciano C, de Leon-Berra R, Hernandez-Gaitan M, Torres H, Creagh O, Rodriguez-Mercado R AJNR Am J Neuroradiol. 2009; 31(3):470-5.
PMID: 19892816 PMC: 7963975. DOI: 10.3174/ajnr.A1855.